Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Pharmacological treatment for psychotic depression

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD004044.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 19 October 2005see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Common Mental Disorders Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Jaap Wijkstra

    Correspondence to: Psychiatry, UMCU, Utrecht, Netherlands

    [email protected]

  • Jeroen Lijmer

    Psychiatry, UMCU, Utrecht, Netherlands

  • Ferdi Balk

    Psychiatry, Medical Centre Haaglanden, The Hague, Netherlands

  • John Geddes

    Department of Psychiatry, University of Oxford, Oxford, UK

  • Willem A Nolen

    Department of Psychiatry, University Hospital Groningen, Groningen, Netherlands

Contributions of authors

J Wijkstra: Development of protocol, coordinating and writing the review, data collection, analysis, primary author report.
J Lijmer: Development of protocol, data collection, analysis, co‐author report.
F Balk: Data collection, co‐author report
J Geddes: External reviewer, co‐author report.
WA Nolen: Development of protocol, data collection, analysis, overall supervision, co‐author report.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Wyeth, Netherlands.

  • AstraZeneca, Netherlands.

Declarations of interest

JW and WN are currently conducting a multi‐centre trial in patients with psychotic depression comparing treatment with imipramine, venlafaxine and venlafaxine plus quetiapine. Wyeth and AstraZeneca are financially supporting this trial. They also supported financially the literature search for this review. JG has received research funding and support from Sanofi‐Aventis and GlaxoSmithKline and is currently in discussion with several other companies that manufacture SSRIs about collaboration on planned independent trials and systematic reviews.

The pharmaceutical company's (AstraZeneca and Wyeth) involvement was two 2500 Euro donations, so we could pay someone (a medical student) searching the literature, downloading articles, and screening the articles. There was absolutely no restriction. Until now they have not seen the review.

Acknowledgements

We would like to thank Dr J. Bruijn, Dr W.W. van den Broek and Dr. R. Zanardi for giving additional information about their studies.

Version history

Published

Title

Stage

Authors

Version

2021 Dec 07

Pharmacological treatment for psychotic depression

Review

Jacolien Kruizinga, Edith Liemburg, Huibert Burger, Andrea Cipriani, John Geddes, Lindsay Robertson, Beatrix Vogelaar, Willem A Nolen

https://doi.org/10.1002/14651858.CD004044.pub5

2015 Jul 30

Pharmacological treatment for psychotic depression

Review

Jaap Wijkstra, Jeroen Lijmer, Huibert Burger, Andrea Cipriani, John Geddes, Willem A Nolen

https://doi.org/10.1002/14651858.CD004044.pub4

2013 Nov 26

Pharmacological treatment for psychotic depression

Review

Jaap Wijkstra, Jeroen Lijmer, Huibert Burger, John Geddes, Willem A Nolen

https://doi.org/10.1002/14651858.CD004044.pub3

2005 Oct 19

Pharmacological treatment for psychotic depression

Review

Jaap Wijkstra, Jeroen Lijmer, Ferdi Balk, John Geddes, Willem A Nolen

https://doi.org/10.1002/14651858.CD004044.pub2

2003 Jan 20

Pharmacological treatment for psychotic depression

Protocol

Jaap Wijkstra, Jeroen Lijmer, Willem A. Nolen

https://doi.org/10.1002/14651858.CD004044

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.